|

[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G. Clinical Trials

3 actively recruiting trials across 1 location

Also known as: [177Lu]Lu DOTA-ABM-5G, [68Ga]Ga DOTA-5G, [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G theranostic pair

Pipeline

Early 1: 1Phase 1: 2

Top Sponsors

  • University of California, Davis3

Indications

  • Cancer3
  • Metastatic Nonsmall Cell Lung Cancer1
  • Locally Advanced Pancreatic Adenocarcinoma1
  • Metastatic Pancreatic Cancer1
  • Metastatic Cancer1

Sacramento, California3 trials

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

University of California Davis

Early 1
Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

The University of California Davis Comprehensive Cancer Center

Phase 1
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

The University of California Davis Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.